Granulocyte colony-stimulating factor therapy for facioscapulohumeral dystrophy: a case report

Journal Title: Progress in Health Sciences - Year 2016, Vol 6, Issue 2

Abstract

We examined the safety and effectiveness of a low dose of analog granulocyte-colony stimulating factor in a 15-year-old boy with facioscapulohumeral dystrophy. The onset of disease was noted at 12 years of age. The physical examination noted general muscle atrophy more pronounced at left side of the body. He was able to walk 300 meters within 6 minute walk test. Granulocyte colony-stimulating factor 5 μg/kg was given subcutaneously daily for 5 days/month for 1, 2, 3, 6 and 12 months. Clinical examination, laboratory tests including blood, biochemical tests, and CD34+ cells were performed. A significant increase of muscle strength in the lower and upper limbs between baseline, and after 3 months of treatment, after 6, and after 12 months was found. He was able to walk 480 meters within 6 minutes after 12 months. Electromyography demonstrated increase of amplitude in the examined in upper and lower limbs after six months compared to baseline. Leukocyte levels remained below 25000/μL. CD34+ increased significantly at day 5 of granulocyte colony-stimulating factor admini-stration. It was safe and well tolerated by the patient. A significant increase in muscle strength in this patient with facioscapulohumeral dystrophy after 3 months of treatment, after 6, and after 12 months since the first treatment course was completed may indicate beneficial effects of granulocyte colony-stimulating factor in this disorder.

Authors and Affiliations

D. Sienkiewicz, W. Kułak, B. Okurowska-Zawada, G. Paszko-Patej, J. Wojtkowski, E. Dmitruk, K. Okulczyk, A. Kalinowska, R. Pogorzelski

Keywords

Related Articles

Patient’s trust in their physicians of the obstetrics and gynecology departments in Grecce

Introduction: Trust in one’s health care provider is essential as it may foster compassion, confi-dentiality of patient medical information, continuity of care, greater support and quality care Purpose: To evaluate pati...

Quality of life and the level of knowledge and utilization of lymphedema prevention principles among mastectomized patients

Introduction: Breast cancer is the most prevalent female malignancy in Poland. Oncological treatment and its adverse effects diminish quality of life of breast cancer patients, which is determined by a number of somatic,...

Nursing care of a child with acute lymphoblastic leukemia

Every year a very large number of children in the world suffer from acute lymphoblastic leukemia, and for years there has been a steady increase in the number of new cases. Acute lymphoblastic leukemia accounts for 75% o...

Evaluation of the students’ knowledge about sunbed and solar radiation

Introduction: In Poland, the incidence of malignant melanoma increases each year. Purpose: To assess the students’ knowledge about sunbed use and side effect of solar radiation. Materials and methods: The study was car...

Lifestyle and health behavior of school aged children in Krasnoyarsk (Russia), Lithuania and Grodno (Belarus)

Purpose: The aim of the study was to analyze the complex interaction of lifestyle-elements of school-aged children in Krasnoyarsk (Russia), Lithuania and Grodno (Belarus) for inactivity overweight and malnutrition that i...

Download PDF file
  • EP ID EP186967
  • DOI 10.5604/01.3001.0009.5165
  • Views 89
  • Downloads 0

How To Cite

D. Sienkiewicz, W. Kułak, B. Okurowska-Zawada, G. Paszko-Patej, J. Wojtkowski, E. Dmitruk, K. Okulczyk, A. Kalinowska, R. Pogorzelski (2016). Granulocyte colony-stimulating factor therapy for facioscapulohumeral dystrophy: a case report. Progress in Health Sciences, 6(2), 175-177. https://europub.co.uk./articles/-A-186967